Adrenal Function in Patients With Newly Diagnosed Lung Cancer

Adrenal Cortical Function in Patients With Newly Diagnosed Lung Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00364624

Enrollment

133

Registered

2006-08-15

Start date

2006-08-31

Completion date

2008-05-31

Last updated

2009-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenal Insufficiency, Lung Cancer

Keywords

lung cancer, adrenal insufficiency

Brief summary

Patients with newly diagnosed lung cancer may have hypofunction of the adrenal cortex either from tumour metastasis or other mechanisms. Since lung cancer patient may have to undergo stressful investigation and treatments, undetected hypofunction of the adrenal cortex may be hazardous. Knowledge of the size of the problem may help determine whether routine check is warranted.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histologically proven primary lung cancer * Newly diagnosed * No specific treatment given * No active infection in the previous week * No general anesthesia in the previous week

Exclusion criteria

* Known adrenal disease * Receiving exogenous systemic corticosteroids * Concomitant illness known to affect adrenal function. e.g. active TB

Countries

China

Outcome results